Blog - Page 112 of 5431 - QualityStocks

WednesdayFeb 26, 2025 10:20 am

QualityStocksNewsBreaks – NVIDIA Corp. (NASDAQ: NVDA) Set to Announce Q4 FY2025 Earnings Amid High Expectations

NVIDIA (NASDAQ: NVDA) is poised to release its fiscal fourth-quarter 2025 earnings report today after market close. Analysts anticipate adjusted earnings of 85 cents per share, a 63% increase from the same period last year, on revenue of $38.1 billion, up 72% year-over-year. This surge is largely attributed to heightened demand for NVIDIA's AI and data center products. Investors are keenly observing how NVIDIA addresses potential challenges, including competition from custom AI chip developers and geopolitical factors affecting sales. As of 8:56 AM EST on February 26, 2025, NVIDIA's stock is trading at $126.63, reflecting a decrease of $3.72, or…

WednesdayFeb 26, 2025 10:15 am

QualityStocksNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Paid Donald Trump Jr. $813K in 2024, Nearly a Quarter of Annual Revenue

Trump Media & Technology Group (NASDAQ: DJT) compensated Donald Trump Jr. $813,000 in 2024, despite his attendance at only two board meetings, accounting for nearly 25% of the company’s total revenue. The payment coincided with Trump Jr. gaining control over more than half of the company's shares, raising questions about the firm's financial structure and governance. As of 8:53 AM EST on Feb. 26, 2025, Trump Media & Technology Group's stock is trading at $23.81, reflecting a decrease of $1.90, or 7.38%, from the previous close. To view the full article, visit https://ibn.fm/zFnaU About Trump Media & Technology Group Trump…

WednesdayFeb 26, 2025 10:00 am

Brera Holdings PLC (NASDAQ: BREA) Seen as a Rare Purchase Opportunity Based Upon Estimated Value of Single Key Player for Serie B Club Juve Stabia

Brera Holdings, an Ireland-based, international holding company with a global portfolio of men’s and women’s sports clubs, remains on track to acquire a 52% stake in Italian Serie B soccer club SS Juve Stabia Its investments are paying off, with Andrea Adorante, a star forward on the team, now having an estimated purchase value of close to €6-7 million, projected to climb to €8-10 million should he continue at his current goal-scoring pace Adorante has scored 12 goals with 2 assists so far in the current football season and could end up with 18 at that pace, winning fans and…

TuesdayFeb 25, 2025 12:55 pm

QualityStocksNewsBreaks – Tuttle Capital Management Featured in Stock2Me Podcast

IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, has announced release of the latest episode of the Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The program features Matthew Tuttle, CEO of Tuttle Capital Management, an investment firm focused on providing innovative strategies while challenging Wall Street's institutional biases. During the engaging conversation with IBN’s Jonathan Keim, Tuttle discusses the appeal of memecoins, excitement in the crypto community for the opportunity to trade beyond Bitcoin and Ether, and advances in artificial intelligence that are reshaping…

TuesdayFeb 25, 2025 11:52 am

QualityStocksNewsBreaks – Twin Hospitality Group Inc. (NASDAQ: TWNP) Completes Spinoff from FAT Brands Inc. (NASDAQ: FAT)

Twin Hospitality (NASDAQ: TWNP), the owner of the Twin Peaks and Smokey Bones restaurant brands, has completed its spinoff from FAT Brands (NASDAQ: FAT), a leading global franchising company and parent company of 18 iconic brands. In conjunction with the spin-off, Twin Hospitality Class A Common Stock began trading under the symbol TWNP on the Nasdaq Global Market. Roth Capital Partners acted as financial advisor for the transaction. For more information, visit https://ibn.fm/q7xjN About Twin Peaks Founded in 2005 in the Dallas suburb of Lewisville, Twin Peaks franchises and owns 115 restaurants in the United States and Mexico. Twin Peaks…

TuesdayFeb 25, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Drives Growth with Strengthened Financial Position and Cutting-Edge Research

One of the most significant challenges facing biotechnology companies is securing adequate funding to sustain research and development efforts. Calidi’s improved financial footing reassures investors and allows the company to focus on achieving key milestones in its research pipeline. The company has been selected to present new data on its RTNova systemic virotherapy platform at the prestigious AACR annual meeting in April 2025. Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company, is making significant strides in the field of cancer immunotherapy. Known for its innovative approach to antitumor virotherapies, Calidi is focused on harnessing the power of its patented…

TuesdayFeb 25, 2025 10:45 am

How Adageis Simplifies Value-Based Care, Boosting Revenue for Healthcare Providers

Adageis streamlines complex insurance contracts, helping providers maximize reimbursements. The company’s AI-driven solutions reduce administrative burden, freeing up time for patient care. Seamless integration with nearly 100 EHR systems ensures a smooth transition to value-based care models. The company’s fintech approach enhances financial performance, with providers seeing up to $75,000 in additional revenue. Adageis projects significant growth, expecting to cover 580,000 patient lives by mid-2025. Healthcare is shifting toward value-based care, where providers are reimbursed for patient outcomes rather than the number of procedures performed. While the model promises higher-quality care at lower costs, it also introduces complex reimbursement structures…

TuesdayFeb 25, 2025 10:00 am

East Coast Cannabis Industry Gets Ready for the New England Cannabis Convention in Boston

Traders, dealers, businesses, and enthusiasts of the cannabis industry are invited to attend the New England Cannabis Convention in Boston from March 21 to March 22, 2025. Operating since 2015, NECANN events are referred to as “MJBizCon East.” The second largest B2B event in the U.S., NECANN witnesses thousands of attendees, with the largest gathering of licensed operators, exhibitors, buyers, and leaders, for the East Coast cannabis market. These events are considered the home base for the Northeast cannabis industry. The Boston NECANN Convention 2025 will also host the prize-giving ceremony for the Boston NECANN Cup winners on March 22,…

TuesdayFeb 25, 2025 9:55 am

QualityStocksNewsBreaks – GivBux Inc. (GBUX) Approves Special Dividend Warrant Issuance

GivBux (OTC: GBUX) announced that its Board of Directors approved a special dividend for shareholders in the form of warrants, authorizing a 1-for-10 warrant issuance that will allow the purchase of additional common stock at a price to be determined later. The dividend underscores the company’s commitment to rewarding loyal shareholders and enabling participation in future growth as it scales its Super App platform globally, said President Umesh Tim Singh. Pricing details and the warrant exercise period will be provided in future communications. To view the full press release, visit https://ibn.fm/oB172 About GivBux Inc. The GivBux Super App revolutionizes shopping…

TuesdayFeb 25, 2025 9:30 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process

Clene (NASDAQ: CLNN) has entered into an agreement with Germany-based APST Research GmbH to utilize its extensive neurofilament light chain (NfL) database in FDA-recommended analyses of CNM-Au8® for treating amyotrophic lateral sclerosis (ALS). APST's repository includes biomarker data from over 4,300 ALS patients, which will help Clene compare NfL changes in NIH-sponsored Expanded Access Protocol participants to matched controls. The results could support Clene’s planned New Drug Application submission for CNM-Au8 under the FDA's Accelerated Approval pathway in the second half of 2025. CEO Rob Etherington emphasized the importance of leveraging real-world evidence to advance potential treatments for ALS. To view…

Site Search

Company Search